Harmony Biosciences Holdings, Inc. (HRMY)
27.72
-0.09
(-0.32%)
USD |
NASDAQ |
Mar 20, 16:00
28.17
+0.45
(+1.62%)
After-Hours: 20:00
Harmony Biosciences Holdings Research and Development Expense (Quarterly) : 49.93M for Dec. 31, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Castle Biosciences, Inc. | 13.44M |
| BioMarin Pharmaceutical, Inc. | 192.41M |
| Amicus Therapeutics, Inc. | 23.74M |
| Iovance Biotherapeutics, Inc. | 71.20M |
| Apellis Pharmaceuticals, Inc. | 74.23M |